1275 related articles for article (PubMed ID: 18052749)
1. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
3. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
4. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
5. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
[TBL] [Abstract][Full Text] [Related]
6. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
7. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
8. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine.
Brock KV; Cortese VS
Vet Ther; 2001; 2(4):354-60. PubMed ID: 19746658
[TBL] [Abstract][Full Text] [Related]
9. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
[TBL] [Abstract][Full Text] [Related]
10. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
[TBL] [Abstract][Full Text] [Related]
11. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination.
Patel JR; Shilleto RW; Williams J; Alexander DC
Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
[TBL] [Abstract][Full Text] [Related]
13. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
14. Reproductive and economic impact following controlled introduction of cattle persistently infected with bovine viral diarrhea virus into a naive group of heifers.
Rodning SP; Givens MD; Marley MS; Zhang Y; Riddell KP; Galik PK; Hathcock TL; Gard JA; Prevatt JW; Owsley WF
Theriogenology; 2012 Oct; 78(7):1508-16. PubMed ID: 22980084
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
[TBL] [Abstract][Full Text] [Related]
16. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
[TBL] [Abstract][Full Text] [Related]
18. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
Brock KV; McCarty K; Chase CC; Harland R
Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
